This test is most useful if any of these apply to you.
Gonorrhea is one of the most common sexually transmitted infections in the world, and it frequently causes no symptoms at all, especially in women and at the throat or rectum. A urine test gives you a straightforward way to find out whether you are carrying it, without waiting for signs that may never appear.
This matters because an untreated infection can move quietly from the lower genital tract to the reproductive organs, where it is linked to infertility, pregnancy complications, and a higher chance of acquiring or passing on HIV. Knowing your result lets you get treated early, protect your partners, and avoid these downstream problems.
The organism behind this test is NG (Neisseria gonorrhoeae), a bacterium that lives on the moist surfaces of the urethra, cervix, rectum, throat, and eyes. A urine test does not measure a substance your body makes. It looks for the genetic material of the bacterium itself, usually with a lab technique called a nucleic acid amplification test (a method that copies tiny amounts of the bacterium's genetic material, DNA or RNA depending on the test, until there is enough to detect).
Because of this, the result is essentially yes or no: the bacterium's genetic material is either found or not found. There is no normal high or low level to interpret, and a positive result signals a likely active urogenital infection rather than something you were exposed to years ago. A urine sample reflects infection in the urethra, which is why it works especially well for men and less completely for other sites.
The most serious reason to catch gonorrhea early is what happens if it spreads upward. From the urethra or cervix, the bacterium can travel to the uterus, fallopian tubes, and surrounding tissue, causing pelvic inflammatory disease, a deep infection of the reproductive organs.
Systematic-review evidence in humans links gonorrhea to pelvic inflammatory disease, later tubal infertility, ectopic pregnancy, and chronic pelvic pain in women. In men, the infection can reach the epididymis and prostate and is associated with infertility, though the comparative numbers here are thinner than for women. The common thread is that damage tends to accumulate silently, which is exactly why testing before symptoms appear has value.
Gonorrhea during pregnancy carries some of the best-documented risks in this entire area. Across large pooled analyses, mothers with the infection had meaningfully higher odds of several poor outcomes for the baby, even in studies where treatment was presumed.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| Pregnant women across 18 studies | Mothers with vs without gonorrhea | About 55% higher odds of preterm birth |
| Pregnant women across 9 studies | Mothers with vs without gonorrhea | Roughly twice the odds of the baby dying around the time of birth |
| About 29,821 pregnancies in one US analysis | Mothers with vs without gonorrhea, despite treatment | About 78% higher odds of premature delivery |
Sources: Vallely et al. meta-analysis (preterm birth, perinatal mortality); Taylor et al. cohort (premature delivery).
The infection is also strongly associated with a serious eye infection in newborns, with roughly four times the odds in affected pregnancies, along with low birth weight and premature rupture of the membranes. What this means for you: if you are pregnant or planning a pregnancy, a urine test is a low-effort way to remove one preventable and treatable driver of these outcomes.
Gonorrhea does not stay in its own lane. Human studies consistently show that the inflammation it causes makes it easier both to acquire HIV and to pass it on, and reviews describe gonorrhea as a meaningful contributor to the ongoing HIV epidemic. Finding and clearing a gonococcal infection is therefore also a form of HIV risk reduction, which is one reason testing is recommended more often for people at higher exposure.
In a minority of cases the bacterium enters the bloodstream and spreads, a state sometimes called disseminated infection. Human reports link this to fever, joint inflammation, tendon inflammation, and, rarely, infection of the heart lining or blood vessels. These complications are uncommon, but they underline that an untreated urogenital infection is not always a contained one.
Urine is an excellent specimen for urethral gonorrhea, particularly in men. Across modern nucleic acid tests, male urine detects the infection correctly about 98 to 99 times out of 100, with very few false alarms. That accuracy reflects the heavy bacterial load an infected male urethra sheds into the urine stream.
The picture is different for other bodies and other exposures. In women, a self- or clinician-collected vaginal swab catches more infections than urine, with pooled detection of about 96.5 out of 100 for the swab versus 90.7 out of 100 for urine. And in men who have sex with men, the throat and rectum are the most common sites, so relying on urine alone would miss close to three-quarters of infections. Urine answers the question well for the urethra, but it does not speak for the throat or rectum.
A urine test is highly reliable, but no test is perfect, and a few specific situations can distort a single reading. Knowing them helps you interpret an unexpected result rather than acting on it blindly.
For an infection like this, timing and repeat testing matter more than any single snapshot. If you test positive and get treated, the point of retesting is not to watch a number drift, it is to confirm the infection is gone and to catch reinfection, which is common.
A practical rhythm looks like this: test when you have symptoms or a possible exposure, treat promptly if positive, and consider a follow-up test of cure about one to two weeks after treatment mainly for a throat (pharyngeal) infection, since guidelines do not routinely call for a test of cure after recommended treatment of uncomplicated genital or rectal infection. Because reinfection from an untreated partner is frequent, retesting around three months after treatment is a reasonable default, and anyone with new or multiple partners benefits from routine screening at least annually, more often with higher exposure. Untreated infection can persist for months, so a past negative does not protect you against a new exposure.
A positive urine result should trigger a clear set of next steps rather than worry. The priority is prompt antibiotic treatment, telling recent partners so they can be tested and treated, and abstaining from sex until treatment is complete, since this is where onward transmission and reinfection are prevented.
Because gonorrhea travels with other infections, a positive result is a reason to test for chlamydia, HIV, and syphilis at the same time if you have not already. If you were exposed through oral or anal sex, add throat and rectal swabs, because urine will not cover those sites. If symptoms persist after treatment or treatment seems to fail, a clinician may order a culture, the one method that can grow the bacterium and test which antibiotics still work, which matters given that resistance to older drugs is now common. A confusing result, such as a positive test in a low-risk setting, is best resolved with confirmatory testing rather than assumption.
Neisseria gonorrhoeae is best interpreted alongside these tests.
Neisseria gonorrhoeae is included in these pre-built panels.